These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 34930269)
41. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy. Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127 [TBL] [Abstract][Full Text] [Related]
43. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Chen Q; Xu L; Liang C; Wang C; Peng R; Liu Z Nat Commun; 2016 Oct; 7():13193. PubMed ID: 27767031 [TBL] [Abstract][Full Text] [Related]
44. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668 [TBL] [Abstract][Full Text] [Related]
45. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence. Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603 [TBL] [Abstract][Full Text] [Related]
46. Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer. Xu M; Zhang C; He S; Xu C; Wei X; Pu K ACS Nano; 2023 May; 17(9):8183-8194. PubMed ID: 37122103 [TBL] [Abstract][Full Text] [Related]
47. Polymeric PD-L1 blockade nanoparticles for cancer photothermal-immunotherapy. Yu Y; Li J; Song B; Ma Z; Zhang Y; Sun H; Wei X; Bai Y; Lu X; Zhang P; Zhang X Biomaterials; 2022 Jan; 280():121312. PubMed ID: 34896861 [TBL] [Abstract][Full Text] [Related]
48. Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors. Nagaya T; Friedman J; Maruoka Y; Ogata F; Okuyama S; Clavijo PE; Choyke PL; Allen C; Kobayashi H Cancer Immunol Res; 2019 Mar; 7(3):401-413. PubMed ID: 30683733 [TBL] [Abstract][Full Text] [Related]
49. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform. Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896 [TBL] [Abstract][Full Text] [Related]
50. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect. Chen B; Huang R; Zeng W; Wang W; Min Y Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501 [TBL] [Abstract][Full Text] [Related]
51. Multimodal Imaging-Guided Photothermal Immunotherapy Based on a Versatile NIR-II Aggregation-Induced Emission Luminogen. Yan D; Wang M; Wu Q; Niu N; Li M; Song R; Rao J; Kang M; Zhang Z; Zhou F; Wang D; Tang BZ Angew Chem Int Ed Engl; 2022 Jul; 61(27):e202202614. PubMed ID: 35344252 [TBL] [Abstract][Full Text] [Related]
52. NIR stimulus-responsive core-shell type nanoparticles based on photothermal conversion for enhanced antitumor efficacy through chemo-photothermal therapy. Sun K; You C; Wang S; Gao Z; Wu H; Tao WA; Zhu X; Sun B Nanotechnology; 2018 Jul; 29(28):285302. PubMed ID: 29671411 [TBL] [Abstract][Full Text] [Related]
53. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors. Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768 [TBL] [Abstract][Full Text] [Related]
54. Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor. Tan YN; Li YP; Huang JD; Luo M; Li SS; Lee AW; Hu FQ; Guan XY Cancer Lett; 2021 Dec; 522():238-254. PubMed ID: 34571084 [TBL] [Abstract][Full Text] [Related]
55. A Self-Delivery Nanodrug Simultaneously Inhibits COX-2/PGE Lai JM; Chen PL; Shi QY; Xie YQ; Jiaerheng G; Liu LH Adv Healthc Mater; 2024 Aug; 13(20):e2400367. PubMed ID: 38704750 [TBL] [Abstract][Full Text] [Related]
56. MOF-Derived Oxygen-Deficient Titania-Mediated Photodynamic/Photothermal-Enhanced Immunotherapy for Tumor Treatment. Jiang X; Huang Z; Liu Z; Wang S; Qiu Y; Su X; Wang Y; Xu H ACS Appl Mater Interfaces; 2024 Jul; 16(27):34591-34606. PubMed ID: 38917296 [TBL] [Abstract][Full Text] [Related]
57. Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors. Luo L; Yang J; Zhu C; Jiang M; Guo X; Li W; Yin X; Yin H; Qin B; Yuan X; Li Q; Du Y; You J J Control Release; 2018 May; 278():87-99. PubMed ID: 29626502 [TBL] [Abstract][Full Text] [Related]
58. A Self-Cascade Penetrating Brain Tumor Immunotherapy Mediated by Near-Infrared II Cell Membrane-Disrupting Nanoflakes via Detained Dendritic Cells. Yalamandala BN; Chen YJ; Lin YH; Huynh TMH; Chiang WH; Chou TC; Liu HW; Huang CC; Lu YJ; Chiang CS; Chu LA; Hu SH ACS Nano; 2024 Jul; 18(28):18712-18728. PubMed ID: 38952208 [TBL] [Abstract][Full Text] [Related]
59. Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy. Liao Y; Zhao C; Pan Y; Guo Y; Liu L; Wu J; Zhang Y; Rao L; Li Q Theranostics; 2024; 14(16):6409-6425. PubMed ID: 39431008 [No Abstract] [Full Text] [Related]
60. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]